Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-03-03, Stock:ABBV, The news for the past five days is as follows:
2020-02-25: NEWS1: Form 8.3 - Abbvie Plc- Amendment.NEWS2: Form 8.3 - ABBVIE INC.NEWS3: AbbVie Stock Falls 3%.NEWS4: FORM 8.3 - ABBVIE INC - Amendment.NEWS5: Form 8.3 - Abbvie Plc - Amendment.
2020-02-26: NEWS1: Coronavirus fears sparks market swings.NEWS2: VENCLEXTA® with Rituximab, a Treatment for Patients With Chronic Lymphocytic Leukemia (CLL), now reimbursed in British Columbia.NEWS3: FORM 8.3 - ABBVIE INC - Amendment.
2020-02-27: NEWS1: AbbVie Could Be One of the Stocks That Recovers Before Others.NEWS2: Form 8.3 - Abbvie Plc.NEWS3: New bill aims to protect medical product supply chain amid coronavirus outbreak.NEWS4: New bill aims to protect medical product supply chain amid coronavirus outbreak.
2020-02-28: NEWS1: AbbVie Provides Update from Phase 3 Study Evaluating VENCLEXTA® (venetoclax) in Combination with Low-Dose Cytarabine in Newly-Diagnosed Patients with Acute Myeloid Leukemia (AML).NEWS2: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS3: FORM 8.3 - ABBVIE PLC.NEWS4: AbbVie Stock Falls 3%.NEWS5: FORM 8.3 - ABBVIE INC - Amendment.
2020-03-02: NEWS1: AbbVie Stock Rises 3%.NEWS2: Form 8.3 - ABBVIE - AMENDMENT.NEWS3: Why You Shouldn't Bet Against AbbVie (ABBV) Stock.NEWS4: AbbVie Is A Notable Coronavirus Responder — But Is ABBV Stock A Buy?.NEWS5: AbbVie's Venclexta Combo Fails in Late-Stage Leukemia Study.NEWS6: Form 8.3 - Abbvie Plc.NEWS7: Chinese Biotech Censured for False Claim on Gilead’s Virus Drug.

Answer: Decrease